Is the stepping‐down approach a better option than multiple daily injections in obese patients with poorly controlled Type 2 diabetes on advanced insulin therapy?

AIM: To determine whether de‐escalating from advanced insulin therapy (AIT) to the combined use of metformin, an SGLT2 inhibitor, a GLP1 receptor agonist and basal insulin is the better option than multiple daily insulin injections (MDI) in obese patients with poorly controlled T2DM. METHODS: This w...

Descripción completa

Detalles Bibliográficos
Autores principales: Naing, Soe, Ramesh, Geeta, Garcha, Jasmine, Poliyedath, Anupama, Khandelwal, Stutee, Mills, Paul K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8029542/
https://www.ncbi.nlm.nih.gov/pubmed/33855207
http://dx.doi.org/10.1002/edm2.204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8029542/
https://www.ncbi.nlm.nih.gov/pubmed/33855207
http://dx.doi.org/10.1002/edm2.204

Ejemplares similares